Literature DB >> 16510373

Drug delivery systems improve pharmaceutical profile and facilitate medication adherence.

Albert I Wertheimer1, Thomas M Santella, Albert J Finestone, Richard A Levy.   

Abstract

Innovations in dosage forms and dose delivery systems across a wide range of medications offer substantial clinical advantages, including reduced dosing frequency and improved patient adherence; minimized fluctuation of drug concentrations and maintenance of blood levels within a desired range; localized drug delivery; and the potential for reduced adverse effects and increased safety. The advent of new large-molecule drugs for previously untreatable or only partially treatable diseases is stimulating the development of suitable delivery systems for these agents. Although advanced formulations may be more expensive than conventional dosage forms, they often have a more favorable pharmacologic profile and can be cost-effective. Inclusion of these dosage forms on drug formulary lists may help patients remain on therapy and reduce the economic and social burden of care.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16510373     DOI: 10.1007/BF02849950

Source DB:  PubMed          Journal:  Adv Ther        ISSN: 0741-238X            Impact factor:   3.845


  3 in total

1.  The role of funding and policies on innovation in cancer drug development.

Authors:  P Kanavos; R Sullivan; G Lewison; W Schurer; S Eckhouse; Z Vlachopioti
Journal:  Ecancermedicalscience       Date:  2010-02-03

2.  Prediction of the partition coefficients using QSPR modeling and simulation of paclitaxel release from the diffusion-controlled drug delivery devices.

Authors:  Anurag Pramanik; Sanjeev Garg
Journal:  Drug Deliv Transl Res       Date:  2018-10       Impact factor: 4.617

3.  Once-nightly sodium oxybate (FT218) demonstrated improvement of symptoms in a phase 3 randomized clinical trial in patients with narcolepsy.

Authors:  Clete A Kushida; Colin M Shapiro; Thomas Roth; Michael J Thorpy; Bruce C Corser; Akinyemi O Ajayi; Russell Rosenberg; Asim Roy; David Seiden; Jordan Dubow; Yves Dauvilliers
Journal:  Sleep       Date:  2022-06-13       Impact factor: 6.313

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.